Oxytocin vaginal - Peptonic Medical
Alternative Names: oxytocin gel; oxytocin topical; VagitocinLatest Information Update: 04 Dec 2021
Price :
$50 *
At a glance
- Originator Peptonic Medical
- Class Amides; Amines; Analgesics; Antihaemorrhagics; Antihyperglycaemics; Antimigraines; Behavioural disorder therapies; Hormones; Macrocyclic lactams; Obesity therapies; Oxytocics; Pyrrolidines
- Mechanism of Action Oxytocin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Discontinued Atrophic vaginitis
Most Recent Events
- 27 Feb 2018 Discontinued - Phase-II for Atrophic vaginitis in United Kingdom and Sweden (Vaginal)
- 20 Sep 2017 Oxytocin vaginal is still in phase IIb trials for Atrophic vaginitis in Sweden (EudraCT2016-000158-36)
- 17 May 2017 Interim efficacy data from the phase II trial in Atrophic vaginitis released by Peptonic Medical